DELAYS in submitting its proposals to the European Commission and potential hold-ups once submitted could see Germany’s adult-use cannabis plans pushed back into 2025.
Originally...
FURTHER details on Germany’s proposed adult-use cannabis market are to be published soon, and they will be avidly consumed with much uncertainty currently surrounding...
PRESS RELEASE
FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...